Prospective familial assessment in dilated cardiomyopathy: Cardiac autoantibodies predict disease development in asymptomatic relatives

Circulation

Volumn 115, Issue 1, 2007, Pages 76-83

  Caforio, Alida L P ^a,b   Mahon, Niall G ^a,c   Baig, M Kamran ^a,d   Tona, Francesco ^b   Murphy, Ross T ^a,e   Elliott, Perry M ^a   McKenna, William J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PADOVA   (Italy)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^d NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^e ST JAMES S HOSPITAL   (Ireland)

Author keywords

Antibodies; Cardiomyopathy; Immunology; Inflammation

Indexed keywords

HEART ANTIBODY;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILY; FEMALE; FOLLOW UP; HEART DILATATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELATIVE; SYSTOLIC DYSFUNCTION;

ADULT; AUTOANTIBODIES; CARDIOMYOPATHY, DILATED; DISEASE PROGRESSION; FAMILY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 33846059259     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.641472     Document Type: Article

References (36)

1. Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited). Immunol Today. 1993;14:426-428.
2. Riley WJ, MacLaren NK, Krischer J, Spillar RP, Silverstein JH, Schaz D, Schwartz Z, Malone J, Shah S, Vadheim C, Rotter JI. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med. 1990;323:1167-1172.
3. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EAM, Bottazzo GF. Quantitation of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet. 1990;335:147-149.
4. Kulmala P, Savola K, Reijonen H, Veijola R, Vahasalo P, Karjalainen J, Tuomilehto-Wolf E, Ilonen J, Tuomilehto J, Akerblom HK, Knip M. Genetic markers, humoral autoimmunity and prediction of type 1 diabetes in siblings of affected children. Diabetes. 2000;49:48-58.
5. Richardson P, McKenna WJ, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation. 1996;93:841-842.
6. Mestroni L, Rocco C, Gregori D, Sinagra G, Di Lenarda A, Miocic S, Vatta M, Pinamonti B, Muntoni F, Caforio ALP, McKenna WJ, Falaschi A, Giacca M, Camerini F; and the Heart Muscle Disease Study Group. Familial dilated cardiomyopathy: evidence for genetic, phenotypic and etiologic heterogeneity. J Am Coll Cardiol. 1999;34:181-190.
7. Caforio ALP, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, Bottazzo GF, McKenna WJ. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet. 1994;344:773-777.
8. MacLellan RW, Lusis AJ. Dilated cardiomyopathy: learning to live with yourself. Nat Med. 2003;12:1455-1456.
9. Mobini R, Maschke H, Waagstein F. New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapy. Autoimmun Rev. 2004;3:277-284.
10. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M, Penninger JM. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med. 2003;9:1484-1490.
11. Okazaki T, Tanaka Y, Nishio R, Mitsuiye T, Mizoguchi A, Wang J, Ishida M, Hiai H, Matsumori A, Minato N, Honjo T. Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice. Nature Med. 2003;9:1477-1483.
12. Elliott JF, Liu J, Bautista-Lopez N, Wallbank SL, Suzuki K, Rayner D, Nation P, Robertson MA, Liu G, Kavanagh KM. Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAβ knockout NOD mice. Proc Natl Acad Sci U S A. 2003;100:13447-13452.
13. Caforio ALP, Goldman JH, Baig KM, Haven AJ, Dalla Libera L, Keeling PJ, McKenna WJ. Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart. 1997;77:62-67.
14. Caforio ALP, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S. Identification of the α and β myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation. 1992;85:1734-1742.
15. Latif N, Baker CS, Dunn MJ, Rose ML, Brady P, Yacoub MH. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and Western blotting. J Am Coll Cardiol. 1993;22:1378-1384.
16. Lauer B, Schannwell M, Kuhl U, Strauer BE, Schultheiss HP. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol. 2000;35:11-18.
17. Limas CJ, Limas C. β-Receptor antibodies and genetics in dilated cardiomyopathy. Eur Heart J. 1991;12(suppl D):175-177.
18. Otto A, Stahle I, Klein R, Berg PA, Pankuweit S, Brandsch R. Antimitochondrial antibodies in patients with dilated cardiomyopathy (anti-M7) are directed against flavoenzymes with covalently bound FAD. Clin Exp Immunol. 1998;111:541-547.
19. Schultheiss HP, Bolte HD. Immunological analysis of autoantibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell Cardiol. 1985;17:603-617.
20. Warraich RS, Dunn MJ, Yacoub MH. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: proinflammatory antibodies in dilated cardiomyopathy patients. Biochem Biophys Res Commun. 1999;259:255-261.
21. 1-adrenoceptor with positive chronotropic effect. Circulation. 1994;89:2760-2767.
22. Caforio ALP, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo GF, McKenna WJ. Novel organ-specific cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol. 1990;15:1527-1534.
23. Mahon NG, Murphy RT, MacRae C, Caforio ALP, Elliott PM, McKenna WJ. Echocardiographic evaluation in asymptomatic relatives of dilated cardiomyopathy patients reveals preclinical disease. Ann Intern Med. 2005;143:108-115.
24. Marriott JB, Goldman JH, Keeling PJ, Baig MK, Dalgleish AG, McKenna WJ. Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart. 1996;75:287-290.
25. Mahon NG, Madden B, Caforio ALP, Haven AJ, Elliott PM, Keogh BE, Davies MJ, McKenna WJ. Immunohistochemical evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol. 2002;39:455-462.
26. Mahon NG, Sharma S, Elliott PM, Baig MK, Norman MW, Barbeyto S, McKenna WJ. Abnormal cardiopulmonary exercise variables in asymptomatic relatives of patients with dilated cardiomyopathy who have left ventricular enlargement. Heart. 2000;83:511-517.
27. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EG, Schoen FJ. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3-14.
28. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation. 1980;62:1054-1061.
29. Mrena S, Savola K, Kulmala P, Reijonen H, Ilonen J, Akerblom HK, Knip M; Childhood Diabetes in Finland Study Group. Genetic modification of risk assessment based on staging of preclinical type 1 diabetes in siblings of affected children. J Clin Endocrinol Metab. 2003;88:2682-2689.
30. Carlquist JF, Menlove RL, Murray MB, O'Connell JB, Anderson JF. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy: validation study and meta-analysis of published HLA association studies. Circulation. 1991;83:515-522.
31. Limas CJ, Iakovis P, Anyfantakis A, Kroupis C, Cokkison DV. Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy. Am J Cardiol. 2004;93:1189-1191.
32. MacLaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, Clare-Salzer M, She JX, Malone J, Crockett S, Schwartz S, Quattrin T, DeSilva M, Vander Vegt P, Notkins A, Krischer J. Only multiple autoantibodies to islet cells(ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives. J Autoimmun. 1999;12:279-287.
33. Kimpimaki T, Kulmala P, Savola K, Kupila A, Korhonen S, Simell T, Ilonen J, Simell O, Knip M. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population. J Clin Endocrinol Metab. 2002;87:4572-4579.
34. Griffiths MM, Encinas JA, Remmers EF, Kuchroo VK, Wilder RL. Mapping autoimmunity genes. Curr Opin Immunol. 1999;11:689-700.
35. Aaltonen J, Bjorses P. Cloning of the APECED gene provides new insight into human autoimmunity. Ann Med. 1999;31:111-116.
36. Knip M, Karjalainen J, Akerblom HK. Islet cell antibodies are less predictive of IDDM among unaffected children in the general population than in sibs of children with diabetes. Diabetes Care. 1998;21:1670-1673.